Literature DB >> 15350942

Preoperative chemoradiation therapy for adenocarcinoma of the pancreas: The Fox Chase Cancer Center experience, 1986-2003.

Ingrid M Meszoely1, Hao Wang, John P Hoffman.   

Abstract

This article reviews the Fox Chase Cancer Center experience of preoperatively and postoperatively delivered adjuvant chemotherapy and radiation therapy for localized adenocarcinoma of the pancreas.

Entities:  

Mesh：

Year:  2004        PMID： 15350942     DOI： 10.1016/j.soc.2004.06.013

Source DB:  PubMed          Journal:  Surg Oncol Clin N Am        ISSN： 1055-3207            Impact factor:   3.495


  8 in total

1.  Perineural and intraneural invasion in posttherapy pancreaticoduodenectomy specimens predicts poor prognosis in patients with pancreatic ductal adenocarcinoma.

Authors:  Deyali Chatterjee; Matthew H Katz; Asif Rashid; Hua Wang; Alina C Iuga; Gauri R Varadhachary; Robert A Wolff; Jeffrey E Lee; Peter W Pisters; Christopher H Crane; Henry F Gomez; James L Abbruzzese; Jason B Fleming; Huamin Wang
Journal:  Am J Surg Pathol       Date:  2012-03       Impact factor: 6.394

Review 2.  Neoadjuvant therapy for pancreatic cancer.

Authors:  Andrew M Lowy
Journal:  J Gastrointest Surg       Date:  2008-02-08       Impact factor: 3.452

3.  Pancreatic intraepithelial neoplasia and histological changes in non-neoplastic pancreas associated with neoadjuvant therapy in patients with pancreatic ductal adenocarcinoma.

Authors:  Deyali Chatterjee; Matthew H Katz; Asif Rashid; Jeannelyn S Estrella; Hua Wang; Gauri R Varadhachary; Robert A Wolff; Jeffrey E Lee; Peter W Pisters; James L Abbruzzese; Jason B Fleming; Huamin Wang
Journal:  Histopathology       Date:  2013-09-20       Impact factor: 5.087

Review 4.  Improving outcomes in pancreatic cancer: key points in perioperative management.

Authors:  José M Alamo; Luis M Marín; Gonzalo Suarez; Carmen Bernal; Juan Serrano; Lydia Barrera; Miguel A Gómez; Jordi Muntané; Francisco J Padillo
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

Review 5.  Adjuvant and neoadjuvant treatment in pancreatic cancer.

Authors:  Marta Herreros-Villanueva; Elizabeth Hijona; Angel Cosme; Luis Bujanda
Journal:  World J Gastroenterol       Date:  2012-04-14       Impact factor: 5.742

6.  Impact of preoperative therapy on patterns of recurrence in pancreatic cancer.

Authors:  Pavlos Papavasiliou; John P Hoffman; Steven J Cohen; Joshua E Meyer; James C Watson; Yun Shin Chun
Journal:  HPB (Oxford)       Date:  2013-02-20       Impact factor: 3.647

7.  Proton therapy may allow for comprehensive elective nodal coverage for patients receiving neoadjuvant radiotherapy for localized pancreatic head cancers.

Authors:  Richard Y Lee; Romaine C Nichols; Soon N Huh; Meng W Ho; Zuofeng Li; Robert Zaiden; Ziad T Awad; Bestoun Ahmed; Bradfors S Hoppe
Journal:  J Gastrointest Oncol       Date:  2013-12

8.  Neoadjuvant therapy in patients with pancreatic cancer: a disappointing therapeutic approach?

Authors:  Carolin Zimmermann; Gunnar Folprecht; Daniel Zips; Christian Pilarsky; Hans Detlev Saeger; Robert Grutzmann
Journal:  Cancers (Basel)       Date:  2011-05-09       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.